Advanced Search

per page
  Report Title Date Provider Type Pgs Price

Alexion Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

02 Oct 2015 Reuters Investment Profile 12 $20.00

ValuEngine Rating and Forecast Report for ALXN

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

04 Oct 2015 ValuEngine, Inc. 11 $25.00

Wright Investors Service Comprehensive Report for Alexion Pharmaceuticals, Inc.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

04 Oct 2015 Wright Reports 56 $75.00

Trading Report for (ALXN). A detailed report, including free correlated market analysis, and updates.

Detailed Trading Report for ALXN. Entry levels, target prices, and risk controls are integral. In addition, free market anal...

04 Oct 2015 Stock Traders Daily 6 $20.00

Thomson Reuters Stock Report - Alexion Pharmaceuticals Inc (ALXN-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

02 Oct 2015 Thomson Reuters Stock Report 12 $25.00

Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ALEXION PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.

02 Oct 2015 Jefferson Research 11 $20.00


02 Oct 2015 Ford Investor Services, Inc. 1 $12.00

Alexion Pharmaceuticals, Inc. (ALXN) - Financial and Strategic SWOT Analysis Review

Alexion Pharmaceuticals, Inc. (ALXN) - Financial and Strategic SWOT Analysis Review Summary Alexion Pharmaceuticals, Inc. (Al...

01 Oct 2015 GlobalData 60 $125.00

Validea Guru Analysis Report for ALXN. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.

Validea's Guru Stock Report uses an interpretation of the published stock-picking strategies developed by 10 investing legend...

25 Sep 2015 Validea 0 $12.00

ALXN.OQ - Event Transcript of Alexion Pharmaceuticals Inc conference call, Sep. 16, 2015 / 4:50PM ET

Edited Event Transcript of ALXN.OQ conference call, Sep. 16, 2015 / 4:50PM ET New York, Sep 17, 2015 (Thomson StreetEve...

16 Sep 2015 Thomson Reuters StreetEvents 8 $75.00